Matsumura R, Igari H, Nakazawa T, Ishikawa S, Tsuyuzaki M, Suzuki K, Yamagishi F
Center of Rheumatology, Allergy & Clinical Immunology, National Hospital Organization Chiba-East Hospital, Chiba, Japan.
Department of Respiratory Medicine, National Hospital Organization Chiba-East Hospital, Chiba, Division of Infection Control, Chiba University Hospital, Chiba, Japan.
Int J Tuberc Lung Dis. 2016 Nov;20(11):1546-1553. doi: 10.5588/ijtld.16.0038.
National hospital for tuberculosis (TB) and rheumatoid arthritis (RA) in Japan.
To compare two interferon-γ release assays (IGRAs), QuantiFERON-TB Gold In-Tube (QFT) and T-SPOT.TB (T-SPOT), in RA patients for detecting latent tuberculous infection (LTBI).
QFT and T-SPOT were conducted concurrently in 230 prospectively enrolled RA patients.
There were no active TB patients. The percentage of QFT- and T-SPOT-positive patients was respectively 8.3% and 5.7%. In patients aged ⩾60 years, these proportions were respectively 12.3% and 7.2%. The percentage of QFT positivity and T-SPOT positivity at age <60 years was respectively 2.2% and 3.3%. After multivariate logistic analysis for QFT positivity, age ⩾60 years and TB suspected based on chest X-ray were selected as independent factors, with adjusted odds ratios of respectively 4.73 and 3.25. No factors were selected for T-SPOT positivity.
QFT had a higher positivity rate. In the light of the previous estimated rate of LTBI in Japan, both IGRAs underestimate LTBI, and neither IGRA has enough capability to detect LTBI.
日本国立结核病与类风湿关节炎医院。
比较两种干扰素-γ释放检测法(IGRAs),即管内定量结核菌素试验(QFT)和结核感染T细胞检测(T-SPOT.TB),在类风湿关节炎(RA)患者中检测潜伏性结核感染(LTBI)的情况。
对230例前瞻性纳入的RA患者同时进行QFT和T-SPOT检测。
无活动性结核患者。QFT阳性患者百分比和T-SPOT阳性患者百分比分别为8.3%和5.7%。在年龄≥60岁的患者中,这些比例分别为12.3%和7.2%。年龄<60岁时QFT阳性百分比和T-SPOT阳性百分比分别为2.2%和3.3%。对QFT阳性进行多因素逻辑回归分析后,年龄≥60岁和基于胸部X线怀疑结核被选为独立因素,调整后的比值比分别为4.73和3.25。未选出与T-SPOT阳性相关的因素。
QFT有较高的阳性率。鉴于日本之前估计的LTBI发生率,两种IGRAs均低估了LTBI,且两种IGRAs均没有足够能力检测LTBI。